Fusion Pharmaceuticalsinc Stock Story
| FUSN Stock | USD 21.26 0.01 0.05% |
About 53% of Fusion PharmaceuticalsI's investor base is interested to short. The analysis of the overall investor sentiment regarding Fusion PharmaceuticalsInc suggests that many traders are impartial. Fusion PharmaceuticalsI's investor sentiment overview provides quick insight into current market opportunities from investing in Fusion PharmaceuticalsInc. The current market sentiment, together with Fusion PharmaceuticalsI's historical and current headlines, can help investors time the market. In addition, many technical investors use Fusion PharmaceuticalsInc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Fusion PharmaceuticalsI stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Fusion daily returns and investor perception about the current price of Fusion PharmaceuticalsInc as well as its diversification or hedging effects on your existing portfolios.
Fusion |
Requested story not found. it has been either deleted or moved. View all stories for Fusion PharmaceuticalsInc.
Fusion PharmaceuticalsI Latest Timeline
Fusion PharmaceuticalsI is listed for 21.26. The company reported the previous year's revenue of 2.07 M. Net Loss for the year was (94.9 M) with loss before overhead, payroll, taxes, and interest of (57.43 M).Check out Fusion PharmaceuticalsI Hype Analysis, Fusion PharmaceuticalsI Correlation and Fusion PharmaceuticalsI Performance. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Fusion Stock analysis
When running Fusion PharmaceuticalsI's price analysis, check to measure Fusion PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fusion PharmaceuticalsI is operating at the current time. Most of Fusion PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Fusion PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fusion PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Fusion PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Fusion PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion PharmaceuticalsI. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.45) | Revenue Per Share 0.032 | Quarterly Revenue Growth (1.00) | Return On Assets (0.25) | Return On Equity (0.49) |
The market value of Fusion PharmaceuticalsInc is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Fusion PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Fusion PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.